In Brief: BRCA1 patent infringement lawsuits
This article was originally published in The Gray Sheet
Executive Summary
BRCA1 patent infringement lawsuits: Myriad Genetics sues OncorMed in Salt Lake City, Utah federal court, alleging that the firm infringes Myriad's patent No. 5,693,473, entitled "17q-Linked Breast and Ovarian Cancer Susceptibility Gene." Myriad filed the suit Dec. 2, the same day the company was issued the patent. The complaint follows OncorMed's Nov. 17 lawsuit alleging that Myriad infringes its own BRCA1-related patent ("The Gray Sheet" Dec. 1, I&W-6). Both firms market tests for detecting mutations in the BRCA1 and BRCA2 genes...